Yongjin Xu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Diabetes, obesity & metabolism

Diabetes technology & therapeutics

Journal of diabetes science and technology

eLife

Abbott Diabetes Care Inc

University at Albany State University of New York (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Abbott Diabetes Care Inc Jan 18 2016

United States

Senior Scientist :: Clinical Affair

Novartis Institutes for BioMedical Research - Jan 16 2016

United States

Investigator III :: Global Discovery Chemistry

Verseon Ltd

United States

Senior Research Scientist :: Computational Chemistry

Johnson and Johnson/SCIOS

United States

Senior Scientist II :: Computational Chemistry

Pharmacia

United States

Scientist :: Structural and Computational Chemistry Unit

Education History

University at Albany State University of New York

United States

PHD :: Chemistry

University at Albany State University of New York

United States

MSC :: Computer Science

Fudan University

China

BSC :: Material Science

Publications

Yongjin Xu, Timothy C Dunn, Richard M Bergenstal, Alan Cheng, Yaghoub Dabiri, Ramzi A Ajjan
Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data. Diabetes technology & therapeutics (2024)
Yongjin Xu, Timothy C Dunn, Richard M Bergenstal, Alan Cheng, Yaghoub Dabiri, Ramzi A Ajjan
Time in Range, Time in Tight Range, and Average Glucose Relationships Are Modulated by Glycemic Variability: Identification of a Glucose Distribution Model Connecting Glycemic Parameters Using Real-World Data. Diabetes technology & therapeutics 26 (7) (2024)
Yongjin Xu, Philippe Oriot, Timothy C Dunn, Michel P Hermans, Yashesvini Ram, Alan Cheng, Ramzi A Ajjan
Evaluation of continuous glucose monitoring-derived person-specific HbA1c in the presence and absence of complications in type 1 diabetes. Diabetes, obesity & metabolism 24 (12) (2022)
Yushi Hirota, Yongjin Xu, Akane Yamamoto, Atsuko Matsuoka, Timothy C Dunn, Wataru Ogawa
Type 1 diabetes iron-deficiency anaemia case report and the clinical relevance of red blood cell lifespan-adjusted glycated haemoglobin. Diabetes, obesity & metabolism (2022)
Yongjin Xu, Richard M Bergenstal, Timothy C Dunn, Yashesvini Ram, Ramzi A Ajjan
Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice. Diabetes, obesity & metabolism 24 (9) (2022)
Yongjin Xu, Yushi Hirota, Ramzi A Ajjan, Akane Yamamoto, Atsuko Matsuoka, Wataru Ogawa, Timothy C Dunn
Accurate prediction of HbA1c by continuous glucose monitoring using a kinetic model with patient-specific parameters for red blood cell lifespan and glucose uptake. Diabetes & vascular disease research 18 (3) (2021)
Fernando Gomez-Peralta, Timothy C Dunn, Katherine Landuyt, Yongjin Xu, Juan-Francisco Merino-Torres
Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ open diabetes research & care 8 (1) (2021)
Yongjin Xu, Richard M Bergenstal, Timothy C Dunn, Ramzi A Ajjan
Addressing shortfalls of laboratory HbA1c using a model that incorporates red cell lifespan. eLife 10 (2021)
Yongjin Xu, Timothy C Dunn, Ramzi A Ajjan
A Kinetic Model for Glucose Levels and Hemoglobin A1c Provides a Novel Tool for Individualized Diabetes Management. Journal of diabetes science and technology 15 (2) (2020)

Yongjin Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yongjin Xu